For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
112
views
28
references
 Top references
cited by
15
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      150
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniques

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          To analyse the development of MRI-guided vacuum-assisted biopsy (VAB) in Switzerland and to compare the procedure with stereotactically guided and ultrasound-guided VAB.

          Methods

          We performed a retrospective analysis of VABs between 2009 and 2011. A total of 9,113 VABs were performed. Of these, 557 were MRI guided.

          Results

          MRI-guided VAB showed the highest growth rate (97 %) of all three procedures. The technical success rates for MRI-guided, stereotactically guided and ultrasound-guided VAB were 98.4 % (548/557), 99.1 % (5,904/5,960) and 99.6 % (2,585/2,596), respectively. There were no significant differences ( P = 0.12) between the MRI-guided and the stereotactically guided procedures. The technical success rate for ultrasound-guided VAB was significantly higher than that for MRI-guided VAB ( P < 0.001). There were no complications using MRI-guided VAB requiring open surgery. The malignancy diagnosis rate for MRI-guided VAB was similar to that for stereotactically guided VAB ( P = 0.35).

          Conclusion

          MRI-guided VAB is a safe and accurate procedure that provides insight into clinical breast findings.

          Key points

          • Three vacuum-assisted breast biopsy (VAB) procedures were compared.

          • Technical success rates were high for all three VAB procedures.

          • Medical complications were relatively low using all three VAB procedures.

          • The use of MRI-guided vacuum-assisted breast biopsy is growing.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.

          A Hocke, M Maringa, H Schild … (2000)
          To compare magnetic resonance (MR) imaging with conventional imaging in screening high-risk women. This prospective trial included 192 asymptomatic and six symptomatic women who, on the basis of personal or family history or genetic analysis, were suspected or proved to carry a breast cancer susceptibility gene. Fifteen breast cancers were identified: nine in the 192 asymptomatic women (six in the first and three in the second screening round) and six in the symptomatic patients. Concerning the asymptomatic women, four of the nine breast cancers were detected and correctly classified with mammography and ultrasonography (US) combined; another two cancers were visible as well-circumscribed masses and were diagnosed as fibroadenomas. MR imaging allowed the correct classification and local staging of all nine cancers. In 105 asymptomatic women with validation of the 1st-year screening results, the sensitivities of mammography, US, and MR imaging were 33%, 33% (mammography and US combined, 44%), and 100%, respectively; the positive predictive values were 30%, 12%, and 64%, respectively. The accuracy of MR imaging is significantly higher than that of conventional imaging in screening high-risk women. Difficulties can be caused by an atypical manifestation of hereditary breast cancers at both conventional and MR imaging and by contrast material enhancement associated with hormonal stimulation.
          Article 0 comments Cited 55 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.

            S. CIRILLO, Maura Tonutti, Cosimo Di Raimondo … (2007)
            To prospectively compare clinical breast examination (CBE), mammography, ultrasonography (US), and contrast material-enhanced magnetic resonance (MR) imaging for screening women at genetic-familial high risk for breast cancer and report interim results, with pathologic findings as standard. Institutional review board of each center approved the research; informed written consent was obtained. CBE, mammography, US, and MR imaging were performed for yearly screening of BRCA1 or BRCA2 mutation carriers, first-degree relatives of BRCA1 or BRCA2 mutation carriers, or women enrolled because of a strong family history of breast or ovarian cancer (three or more events in first- or second-degree relatives in either maternal or paternal line; these included breast cancer in women younger than 60 years, ovarian cancer at any age, and male breast cancer at any age). Two hundred seventy-eight women (mean age, 46 years +/- 12 [standard deviation]) were enrolled. Breast cancer was found in 11 of 278 women at first round and seven of 99 at second round (14 invasive, four intraductal; eight were
            Article 0 comments Cited 45 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Image-guided breast biopsy: state-of-the-art.

              E.A.M. O'Flynn, A.R.M Wilson, M.J. Michell (2010)
              Percutaneous image-guided breast biopsy is widely practised to evaluate predominantly non-palpable breast lesions. There has been steady development in percutaneous biopsy techniques. Fine-needle aspiration cytology was the original method of sampling, followed in the early 1990s by large core needle biopsy. The accuracy of both has been improved by ultrasound and stereotactic guidance. Larger bore vacuum-assisted biopsy devices became available in the late 1990s and are now commonplace in most breast units. We review the different types of breast biopsy devices currently available together with various localization techniques used, focusing on their advantages, limitations and current controversial clinical management issues.
              Article 0 comments Cited 40 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Contributors
                : +41-56-4863816 , +41-56-4863809 , imschweiler@gmail.com
                Journal
                Journal ID (nlm-ta): Eur Radiol
                Journal ID (iso-abbrev): Eur Radiol
                Title: European Radiology
                Publisher: Springer Berlin Heidelberg (Berlin/Heidelberg )
                ISSN (Print): 0938-7994
                ISSN (Electronic): 1432-1084
                Publication date (Electronic): 27 August 2013
                Publication date PMC-release: 27 August 2013
                Publication date (Print): 2014
                Volume: 24
                Pages: 128-135
                Affiliations
                [ ]Institute for Radiology, Kantonspital Baden AG, Im Ergel 1, 5404 Baden, Switzerland
                [ ]Institute for Radiology, Kantonspital Aarau AG, Tellstrasse 15, 5001 Aarau, Switzerland
                [ ]Clinica Sant’ Anna, Lugano, Via Sant`Anna 1, 6924 Sorengo, Switzerland
                [ ]Adjumed Services AG, Birmensdorferstrasse 470, 8055 Zurich, Switzerland
                [ ]Division of Biostatistics, Institute for Social and Preventive Medicine, University of Zurich, Hirschengraben 84, 8001 Zürich, Switzerland
                [ ]Breast Centre, Seefeldstrasse 214, 8008 Zurich, Switzerland
                Article
                Publisher ID: 2989
                DOI: 10.1007/s00330-013-2989-5
                PMC ID: 3889280
                PubMed ID: 23979106
                SO-VID: eef44f3a-2f13-4418-bc10-420774eccee5
                Copyright © © The Author(s) 2013
                License:

                Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

                History
                Date received : 11 April 2013
                Date revision received : 26 June 2013
                Date accepted : 9 July 2013
                Categories
                Subject: Breast
                Custom metadata
                issue-copyright-statement © European Society of Radiology 2014

                ScienceOpen disciplines: Radiology & Imaging
                Keywords: breast carcinoma,image-guided biopsy,mri-guided biopsy,vacuum-assisted biopsy,malignancy rate
                Data availability:
                ScienceOpen disciplines: Radiology & Imaging
                Keywords: breast carcinoma, image-guided biopsy, mri-guided biopsy, vacuum-assisted biopsy, malignancy rate

                Comments

                Comment on this article

                scite_

                Similar content150

                See all similar

                Cited by14

                See all cited by

                Most referenced authors253

                See all reference authors